Paediatrics Search
Paediatrics Paediatrics
gastroesophageal%20reflux%20disease%20in%20children
GASTROESOPHAGEAL REFLUX DISEASE IN CHILDREN

Gastroesophageal reflux is categorized as a disease [gastroesophageal reflux disease (GERD)] when reflux is associated with warning signs &/or complications, & requires further evaluation.

It is more common in formula-fed infants than in purely breastfed infants.

There is increased incidence in infants at 4 months of age.

Drug Information

Indication: Peptic ulcer disease associated w/ Helicobacter pylori.

Indication: Symptomatic relief of nausea & vomiting of functional, organic, infectious or dietary origin, induced by r...

Indication: Healing & maintenance of erosive or ulcerative GERD. Healing of duodenal ulcers. Pathological hypersecreto...

Indication: Active duodenal, benign gastric, stomal & recurrent ulceration, persistent dyspeptic symptoms w/ or w/o ul...

Baroscon Double Action
calcium carbonate + sodium alginate + sodium bicar...

Indication: Symptomatic treatment of GERD eg, acid regurgitation, heartburn & indigestion; hyperacidity symptoms.

Indication: Duodenal & gastric ulcer, reflux esophagitis, Zollinger-Ellison syndrome.

Indication: Duodenal & gastric ulcer, Zollinger-Ellison syndrome & other conditions associated w/ gastric hyperaci...

Indication: Peptic ulcer associated w/ H pylori.

Indication: Reflux disease & associated symptoms. Prevention of gastroduodenal ulcers induced by NSAIDs in patients at...

Indication: 20 mg Mild GERD & associated symptoms (eg, heartburn, acid regurgitation, pain on swallowing). Long-term m...

1  /  9
1  /  9
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Obesity protects against diabetic retinopathy in type 2 diabetes
6 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Enzalutamide shows potential survival benefit in metastatic hormone-sensitive prostate cancer
Roshini Claire Anthony, 5 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.
Aspirin may increase rate of haemorrhagic events in elderly hypertensive patients
07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
Opioids unlikely to be helpful for long-term management of chronic noncancer pain
5 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.